Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome-Reference-Cited by-同舟云学术

Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome

Published:2017-11-01 Issue:1 Volume:59 Page:183-190
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Chen Shi,Li Ran,Lu Lin,Duan Lian,Zhang Xuebin,Tong Anli,Pan Hui,Zhu Huijuan,Lu Zhaolin

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1007/s12020-017-1436-9/fulltext.html

Reference25 articles.

1. A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386(9996), 913–927 (2015). https://doi.org/10.1016/S0140-6736(14)61375-1

2. W.F. Young, J.A. Carney, B.U. Musa, N.M. Wulffraat, J.W. Lens, H.A. Drexhage, Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N. Engl. J. Med. 321(24), 1659–1664 (1989). https://doi.org/10.1056/nejm198912143212407

3. C.A. Stratakis, L.S. Kirschner, J.A. Carney, Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J. Clin. Endocrinol. Metab. 86(9), 4041–4046 (2001). https://doi.org/10.1210/jcem.86.9.7903

4. C.A. Stratakis, N. Sarlis, L.S. Kirschner, J.A. Carney, J.L. Doppman, L.K. Nieman, G.P. Chrousos, D.A. Papanicolaou, Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann. Intern. Med. 131(8), 585–591 (1999)

5. D. Vezzosi, F. Tenenbaum, L. Cazabat, F. Tissier, M. Bienvenu, C.A. Carrasco, M. Laloi-Michelin, G. Barrande, H. Lefebvre, S. Hieronimus, A. Tabarin, X. Bertagna, P. Legmann, M.C. Vantyghem, J. Bertherat, Hormonal, radiological, NP-59 scintigraphy, and pathological correlations in patients with Cushing’s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). J. Clin. Endocrinol. Metab. 100(11), 4332–4338 (2015). https://doi.org/10.1210/jc.2015-2174

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review;Frontiers in Endocrinology;2024-06-26

2. Adrenal Cushing’s syndrome in children;Frontiers in Endocrinology;2023-12-12

3. Treatment of Primary Pigmented Nodular Adrenocortical Disease;Hormone and Metabolic Research;2022-09-21

4. Cushing´s syndrome due to bilateral adrenal cortical disease: Bilateral macronodular adrenal cortical disease and bilateral micronodular adrenal cortical disease;Frontiers in Endocrinology;2022-08-05

5. Clinical and genetic heterogeneity of micronodular adrenal hyperplasia;Endocrine Surgery;2021-10-19